Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ.
Schulmann K, et al. Among authors: beer dg.
Oncogene. 2005 Jun 9;24(25):4138-48. doi: 10.1038/sj.onc.1208598.
Oncogene. 2005.
PMID: 15824739